RE: Outstanding Achievement5 May 2023 16:49
Well said Krone - I think it is about time that there is recognition for the BoDs efforts. It is very clear that we cannot "go it alone" commercially. There is far too much work to be done in that respect. The scientific development is nearing completion so thoughts will be turning to Trials, manufacturing, distribution not to mention all of the commercial departments such as sales/marketing etc: No the strategy is clearly stated and clearly being pursued with licensing the way forwards, or, as Basser suggests, a buyout that allows the BoD to exercise their own exit strategies. I suspect that there are several of us here who would also welcome a buyout in order to take away the angst of decision making during a rising shareprice. 1801 success is critical given that 1802 is out of the same stable so to speak. I am sure all will become clear.